Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cemtrex (CETXP) Short-term Investments (2019 - 2025)

Cemtrex's Short-term Investments history spans 9 years, with the latest figure at $839215.0 for Q3 2025.

  • For Q3 2025, Short-term Investments fell 18.57% year-over-year to $839215.0; the TTM value through Sep 2025 reached $839215.0, down 18.57%, while the annual FY2025 figure was $839215.0, 18.57% down from the prior year.
  • Short-term Investments reached $839215.0 in Q3 2025 per CETXP's latest filing, down from $899008.0 in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $4.6 million in Q1 2022 to a low of $13307.0 in Q4 2023.
  • Average Short-term Investments over 5 years is $676518.1, with a median of $452175.0 recorded in 2021.
  • Peak YoY movement for Short-term Investments: crashed 99.7% in 2023, then surged 7828.91% in 2024.
  • A 5-year view of Short-term Investments shows it stood at $14960.0 in 2021, then decreased by 8.28% to $13721.0 in 2022, then dropped by 3.02% to $13307.0 in 2023, then soared by 7828.91% to $1.1 million in 2024, then fell by 20.46% to $839215.0 in 2025.
  • Per Business Quant, the three most recent readings for CETXP's Short-term Investments are $839215.0 (Q3 2025), $899008.0 (Q2 2025), and $1.1 million (Q1 2025).